DIR Technologies
Thermographic Drug Inspection Solutions
Company Overview
Snapshot
Founded in June 2009 by Eran Sinbar and Yoav Weinstein, DIR Technologies operated with 1–10 employees. The company raised $10,000,000 across one funding round from Pfizer. In December 2016, DIR Technologies secured funding from Pfizer, a significant milestone in its development.
Business overview
DIR Technologies develops and manufactures advanced solutions for inspecting pharmaceuticals, leveraging thermal-imaging techniques. Its core technology focuses on applications such as quality control, process control, and the identification of counterfeit drugs. The company's technology offers the potential to inspect every package on a production line without breaking seals, moving beyond standard periodic sampling methods. DIR Technologies operates within the Health Tech & Life Sciences sector, specifically targeting the Pharma & Medical Biotechnology industry.
Strategic signal
In November 2015, DIR Technologies was recognized for developing a revolutionary drug safety system, highlighting the company's innovative approach to pharmaceutical inspection. This signals the potential for significant advancements in drug quality control and anti-counterfeiting measures within the industry, demonstrating the company's impact on enhancing pharmaceutical safety and integrity.
Log in to access full profile ›Company Intelligence Q&A
- What is DIR Technologies' primary focus?
- DIR Technologies develops and manufactures solutions for inspecting pharmaceuticals, utilizing advanced thermal-imaging techniques for quality control, process control, and counterfeit drug identification.
- When was DIR Technologies founded?
- DIR Technologies was founded in June 2009.
- Which company partnered with DIR Technologies in 2015?
- In 2015, DIR Technologies and Pfizer signed a five-year agreement to apply DIR's inspection method to several of Pfizer's production lines.
- What was a key funding event for DIR Technologies?
- In December 2016, DIR Technologies raised $10,000,000 in a funding round from Pfizer.
- What is the status of DIR Technologies?
- DIR Technologies ceased to operate in June 2019.